Serum and tissue cage fluid concentrations of ciprofloxacin after oral administration of the drug to healthy dogs
- 1 June 1990
- journal article
- research article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 51 (6) , 896-900
- https://doi.org/10.2460/ajvr.1990.51.06.896
Abstract
Summary: Ciprofloxacin, a fluoroquinolone antimicrobial agent, was administered orally to 4 healthy dogs at dosage of approximately 11 and 23 mg/kg of body weight, every 12 hours for 4 days, with a 4-week interval between dosing regimens. Serum and tissue cage fluid (tcf) concentrations of ciprofloxacin were measured after the first and seventh dose of each dosing regimen. The peak concentration was greatest in the serum after multiple doses of 23 mg/kg (mean ± sem; 5.68 ± 0.54 μg/ml) and least in the tcf after a single dose of 11 mg/kg (0.43 ± 0.54 μg/ml). The time to peak concentration was not influenced by multiple dosing or drug dose, but was longer for tcf (6.41 ± 0.52 hour) than for serum (1.53 ± 0.52 hour). Accumulation of ciprofloxacin was reflected by the area under the concentration curve from 0 to 12 hours after administration (AUC0→12). The AUC0→12 was greatest in the serum after multiple doses of 23 mg/kg (31.95 ± 1.90 μg·h/ml) and least in the tcf after a single dose of 11 mg/kg (3.87 ± 1.90 μg·h/ml). The elimination half-life was not influenced by multiple dosing or dose concentration, but was greater for tcf (14.59 ± 1.91 hours) than for serum (5.14 ± 1.91 hours). The percentage of tcf penetration (AUCTCF/AUCserum ) was greater after multiple doses (95.76 ± 6.79%) than after a single dose (55.55 ± 6.79%) and was not different between doses of 11 and 23 mg/kg. Both dosing regimens of ciprofloxacin resulted in continuous serum and tcf concentrations > 90% of the minimal inhibitory concentration for the aerobic and facultative anaerobic clinical isolates tested, including Pseudomonas aeruginosa.This publication has 12 references indexed in Scilit:
- The emergence of resistance to ciprofloxacin during treatment of experimental Staphylococcus aureus endocarditisJournal of Antimicrobial Chemotherapy, 1987
- Distribution of cephapirin into a tissue chamber implanted subcutaneously in horsesJournal of Veterinary Pharmacology and Therapeutics, 1987
- Effect of dose size on bioavailability of ciprofloxacinAntimicrobial Agents and Chemotherapy, 1987
- Absolute oral bioavailability of ciprofloxacinAntimicrobial Agents and Chemotherapy, 1986
- Tissue penetration of ciprofloxacin after single and multiple dosesAntimicrobial Agents and Chemotherapy, 1986
- Pharmacokinetics and tolerance of ciprofloxacin after sequential increasing oral dosesAntimicrobial Agents and Chemotherapy, 1986
- Tissue distribution of ciprofloxacin following oral and intravenous administrationInfection, 1985
- Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteersAntimicrobial Agents and Chemotherapy, 1984
- Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteriaAntimicrobial Agents and Chemotherapy, 1984
- Pharmacokinetics and tissue penetration of ciprofloxacinAntimicrobial Agents and Chemotherapy, 1983